Ghost Tree Capital, LLC Aldeyra Therapeutics, Inc. Transaction History

Ghost Tree Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	BUY	$7.94 - $11.31 $794,000 - $1.13 Million	100,000 Added 16.67%	700,000 $6.15 Million
Q2 2021 Aug 11, 2021	SELL	$10.44 - $14.85 $522,000 - $742,500	-50,000 Reduced 7.69%	600,000 $6.8 Million
Q4 2020 Feb 16, 2021	SELL	$6.31 - $8.13 $3.79 Million - $4.88 Million	-600,000 Reduced 48.0%	650,000 $4.46 Million
Q3 2020 Nov 16, 2020	BUY	$4.0 - $7.53 $1 Million - $1.88 Million	250,000 Added 25.0%	1,250,000 $9.26 Million
Q2 2020 Aug 14, 2020	BUY	$1.97 - $5.05 $1.97 Million - $5.05 Million	1,000,000 New	1,000,000 $4.17 Million

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $283M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.